| 1) Core items |
| Test code |
Test name |
Clinical description |
| E424 |
Beta-HCG (Quantitative) |
Used to confirm pregnancy and estimate gestational age |
| M722 |
GBS culture, ID only |
Detection of Group B Streptococcus (GBS) infection before delivery to prevent neonatal sepsis |
| C180 |
Glucose [P] |
First-line screening test for early detection of gestational diabetes |
| S418 |
HIV-1/-2 Ag and Ab Screen |
Confirmation of HIV infection for prevention of vertical (mother-to-child) transmission |
| S423 |
Measles IgG |
Measles |
| S424 |
Mumps IgG |
Mumps |
| S019 |
Rapid plasma reagin (RPR) [S] |
Screening test for syphilis and early pregnancy assessment of fetal infection risk |
| S413 |
Rubella Ab, IgG |
Assessment of immune status to prevent congenital rubella syndrome |
| E455 |
Somatomedin C (insulin-like growth factor-1, IGF-1) |
Essential first-line assessment as an indirect marker of growth hormone (GH) activity |
| E403 |
Thyroid Stimulating Hormone (TSH) |
Measurement of thyroid-stimulating hormone (TSH) concentration |
| E406 |
Thyroxine (T4), Free |
Measurement of free thyroxine (Free T4) concentration |
| E865 |
Total Human Chorionic Gonadotropin (hCG), Tumor Marker |
Used to evaluate fetal status and risk of miscarriage |
| 2) Optional items |
| Test code |
Test name |
Clinical description |
| S411/S412 |
Cytomegalovirus (CMV) Ab, IgG / IgM |
Evaluation of potential fetal auditory and visual abnormalities |
| B150/S589 |
HSV type Ⅰ IgM / IgG |
Assessment of fetal infection risk in primary infection with herpes simplex virus type 1 (HSV-1) |
| B149/S590 |
HSV type Ⅱ IgM / IgG |
Herpes simplex virus type 2 (HSV-2); used to guide delivery method in infected mothers |
| S414 |
Rubella Ab, IgM |
Assessment of infection history in early pregnancy to prevent fetal infection |
| N062 |
sFlt-1/PlGF ratio |
Evaluation of prognosis and severity in pregnant women at high risk for preeclampsia |
| S429/S959 |
Varicella-Zoster virus IgG / IgM |
Confirmation of varicella infection status to prevent fetal infection |
| 3) Newborn screening for congenital disorders |
| Test code |
Test name |
Clinical description |
| GA0E |
Integrated Test 1st |
Early screening test for chromosomal abnormalities (gestational weeks 11?22) |
| N800 |
Newborn screening test (NST & LSD) |
Early diagnosis of congenital metabolic disorders |
